Publication: Evaluation of <sup>1</sup>H-magnetic resonance spectroscopy of breast cancer pre- and postgadolinium administration
dc.contributor.author | Bonnie N. Joe | en_US |
dc.contributor.author | Victoria Y. Chen | en_US |
dc.contributor.author | Nouha Salibi | en_US |
dc.contributor.author | Pornpim Fuangtharntip | en_US |
dc.contributor.author | Charles F. Hildebolt | en_US |
dc.contributor.author | Kyongtae T. Bae | en_US |
dc.contributor.other | University of California, San Francisco | en_US |
dc.contributor.other | Siemens USA | en_US |
dc.contributor.other | Mahidol University | en_US |
dc.contributor.other | Washington University School of Medicine in St. Louis, Mallinckrodt Institute of Radiology | en_US |
dc.date.accessioned | 2018-06-21T08:26:43Z | |
dc.date.available | 2018-06-21T08:26:43Z | |
dc.date.issued | 2005-07-01 | en_US |
dc.description.abstract | Objectives: We sought to evaluate spectroscopic measurements in breast cancer and compare variability in choline peak parameters related to contrast administration versus that inherent to repeated measurements. Materials and Methods: Single-voxel, proton spectroscopy measurements were obtained before and after the administration of gadolinium on 15 patients with ≥1-cm breast cancers. The protocol was repeated on a separate day in 7 patients. Results: Postcontrast spectra demonstrated a significant increase in choline peak linewidth (day 1: 15% ± 21%, P = 0.03; day 2: 19% ± 12%, P = 0.001) and decrease in choline peak area (day 1: 11% ± 9% (P < 0.001); day 2: 18% ± 21% (P = 0.03). A variance-components analysis indicated that day-to-day variation in linewidth accounted for 0.0% of the total variation in width measurements and was not significant (P = 0.85). Day-to-day variation in area was also not significant (0.0%, P = 0.95). Conclusions: Contrast administration caused significant increases in choline peak linewidth and decreases in choline peak area in spectroscopic measurements of breast cancer. Copyright © 2005 by Lippincott Williams & Wilkins. | en_US |
dc.identifier.citation | Investigative Radiology. Vol.40, No.7 (2005), 405-411 | en_US |
dc.identifier.doi | 10.1097/01.rli.0000167125.79212.5d | en_US |
dc.identifier.issn | 00209996 | en_US |
dc.identifier.other | 2-s2.0-20844433248 | en_US |
dc.identifier.uri | https://repository.li.mahidol.ac.th/handle/20.500.14594/16947 | |
dc.rights | Mahidol University | en_US |
dc.rights.holder | SCOPUS | en_US |
dc.source.uri | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=20844433248&origin=inward | en_US |
dc.subject | Medicine | en_US |
dc.title | Evaluation of <sup>1</sup>H-magnetic resonance spectroscopy of breast cancer pre- and postgadolinium administration | en_US |
dc.type | Article | en_US |
dspace.entity.type | Publication | |
mu.datasource.scopus | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=20844433248&origin=inward | en_US |